Developmental function in toddlers with sickle cell anemia

Pediatrics

Volumn 131, Issue 2, 2013, Pages

  Armstrong, F Daniel ^a   Elkin, T David ^b   Brown, R Clark ^c   Glass, Penny ^d   Rana, Sohail ^e   Casella, James F ^f   Kalpatthi, Ram V ^g   Pavlakis, Steven ^h   Mi, Zhibao ⁱ   Wang, Winfred C ^j  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Children's Mercy Hospital   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ Clinical Trials & Surveys Corp   (United States)

^j ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

more..

Author keywords

Bayley Scales; Cognitive development; Sickle cell disease; Toddlers; Transcranial Doppler

Indexed keywords

HEMOGLOBIN;

ADAPTIVE BEHAVIOR; AGE DISTRIBUTION; ARTICLE; BEHAVIOR DISORDER; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CHILD; CHILD BEHAVIOR; CLINICAL EVALUATION; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; FUNCTIONAL STATUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCOME; INFANT; MALE; MENTAL DEVELOPMENT; MENTAL FUNCTION; MENTAL HEALTH; MENTAL PERFORMANCE; NERVE CELL DIFFERENTIATION; ONSET AGE; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; SCORING SYSTEM; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; AGE FACTORS; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BLOOD FLOW VELOCITY; BRAIN; BRAIN DAMAGE, CHRONIC; CHILD BEHAVIOR DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBINOMETRY; HUMANS; HYDROXYUREA; INFANT; MALE; PERSONALITY ASSESSMENT; PSYCHOMOTOR DISORDERS; SOCIALIZATION; SYMPTOM ASSESSMENT; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84873461553     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-0283     Document Type: Article

References (23)

1. Armstrong FD, Thompson RJ Jr., Wang W, et al Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics. 1996;97(6 pt 1): 864-870
2. Bernaudin F, Verlhac S, Fréard F, et al. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol. 2000;15(5):333-343
3. Gold JI, Johnson CB, Treadwell MJ, Hans N, Vichinsky E. Detection and assessment of stroke in patients with sickle cell disease: neuropsychological functioning and magnetic resonance imaging. Pediatr Hematol Oncol. 2008;25(5):409-421
4. Schatz J, Finke R, Roberts CW. Interactions of biomedical and environmental risk factors for cognitive development: a preliminary study of sickle cell disease. J Dev Behav Pediatr. 2004;25(5):303-310
5. DeBaun MR, Schatz J, Siegel MJ, et al. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology. 1998;50(6):1678-1682
6. Armstrong FD. Neurodevelopment and chronic illness: mechanisms of disease and treatment. Ment Retard Dev Disabil Res Rev. 2006;12(3):168-173
7. Kral MC, Brown RT. Transcranial Doppler ultrasonography and executive dysfunction in children with sickle cell disease. J Pediatr Psychol. 2004;29(3):185-195
8. Wang W, Enos L, Gallagher D, et al Cooperative Study of Sickle Cell Disease. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):391-397
9. Vichinsky EP, Neumayr LD, Gold JI, et al Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA. 2010;303(18):1823-1831
10. Wang WC, Grover R, Gallagher D, Espeland M, Fandal A. Developmental screening in young children with sickle cell disease: results of a cooperative study. Am J Pediatr Hematol Oncol. 1993;15(1):87-91
11. Thompson RJ Jr., Gustafson KE, Bonner MJ, Ware RE. Neurocognitive development of young children with sickle cell disease through three years of age. J Pediatr Psychol. 2002;27(3):235-244
12. Wang WC, Pavlakis SG, Helton KJ, et al BABY HUG Investigators. MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer. 2008;51 (5):643-646
13. Thompson BW, Miller ST, Rogers ZR, et al. The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design. Pediatr Blood Cancer. 2010;54(2):250-255
14. Pavlakis SG, Rees RC, Huang X, et al BABY HUG Investigators. Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial. Pediatr Blood Cancer. 2010; 54(2):256-259
15. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288-294
16. Wang WC, Langston JW, Steen RG, et al. Abnormalities of the central nervous system in very young children with sickle cell anemia. J Pediatr. 1998;132(6):994-998
17. Kwiatkowski JL, Zimmerman RA, Pollock AN, et al. Silent infarcts in young children with sickle cell disease. Br J Haematol. 2009;146 (3):300-305
18. Wang WC, Morales KH, Scher CD, et al STOP Investigators. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial. J Pediatr. 2005; 147(2):244-247
19. Gladwin MT. Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation. Adv Exp Med Biol. 2006;588:189-205
20. Gladwin MT, Shelhamer JH, Ognibene FP, et al. Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br J Haematol. 2002;116(2):436-444
21. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37-47
22. Wang WC, Ware RE, Miller ST, et al; BABY HUG investigators. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377(9778): 1663-1672
23. Casella JF, King AA, Barton B, et al. Design of the silent cerebral infarct transfusion (SIT) trial. Pediatr Hematol Oncol. 2010;27 (2):69-89